开云app官网登录入口网页版-官方正版

#蛋白酶#

140篇内容 | 2475人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1945257, encodeId=a552194525ee0, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, objectTitle=《新英格兰医学杂志》发表Fazirsiran治疗α-1抗胰蛋白酶缺乏症患者的二期研究结果, objectType=article, longId=730850, objectId=e34ae3085081, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e34ae3085081, replyNumber=0, likeNumber=95, createdTime=2023-05-31, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e34ae3085081, moduleTitle=《新英格兰医学杂志》发表Fazirsiran治疗α-1抗胰蛋白酶缺乏症患者的二期研究结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e34ae3085081)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945254, encodeId=d61a1945254aa, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, objectTitle=众生药业抗新型冠状病毒3CL蛋白酶抑制剂一类创新药物RAY1216片获准IND, objectType=article, longId=727033, objectId=76d9e2703326, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76d9e2703326, replyNumber=0, likeNumber=78, createdTime=2023-01-07, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76d9e2703326, moduleTitle=众生药业抗新型冠状病毒3CL蛋白酶抑制剂一类创新药物RAY1216片获准IND, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=76d9e2703326)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945259, encodeId=d063194525928, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, objectTitle=胃蛋白酶原（PG）临床应用大全！, objectType=article, longId=738302, objectId=a144e3830212, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a144e3830212, replyNumber=0, likeNumber=83, createdTime=2022-10-13, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a144e3830212, moduleTitle=胃蛋白酶原（PG）临床应用大全！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a144e3830212)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945252, encodeId=5e0a1945252b9, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, objectTitle=欧洲药理学杂志：组织蛋白酶 S 抑制剂 ASP1617 作为系统性红斑狼疮治疗的潜在益处, objectType=article, longId=295713, objectId=39ac295e1352, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39ac295e1352, replyNumber=0, likeNumber=78, createdTime=2022-07-19, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39ac295e1352, moduleTitle=欧洲药理学杂志：组织蛋白酶 S 抑制剂 ASP1617 作为系统性红斑狼疮治疗的潜在益处, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=39ac295e1352)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945250, encodeId=35b1194525052, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, objectTitle=J Am Acad Dermatol ：组织蛋白酶S抑制剂对中、重度银屑病患者疗效和安全性的研究, objectType=article, longId=293131, objectId=686729313109, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=686729313109, replyNumber=0, likeNumber=89, createdTime=2022-07-29, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=686729313109, moduleTitle=J Am Acad Dermatol ：组织蛋白酶S抑制剂对中、重度银屑病患者疗效和安全性的研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=686729313109)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945256, encodeId=b7d21945256ff, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, objectTitle=NEJM：Fazirsiran 治疗α1-抗胰蛋白酶缺乏症相关的肝病, objectType=article, longId=730625, objectId=6524e3062522, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6524e3062522, replyNumber=0, likeNumber=65, createdTime=2022-09-16, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6524e3062522, moduleTitle=NEJM：Fazirsiran 治疗α1-抗胰蛋白酶缺乏症相关的肝病, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6524e3062522)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945255, encodeId=bd5f19452556e, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, objectTitle=A&R：PSMD12 的单倍体不足导致蛋白酶体功能障碍和亚临床自身炎症, objectType=article, longId=730298, objectId=9b41e3029846, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b41e3029846, replyNumber=0, likeNumber=76, createdTime=2022-11-05, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b41e3029846, moduleTitle=A&R：PSMD12 的单倍体不足导致蛋白酶体功能障碍和亚临床自身炎症, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9b41e3029846)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945258, encodeId=eb121945258d9, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, objectTitle=胃蛋白酶原（PG）临床应用大全！, objectType=article, longId=737449, objectId=33d9e3744902, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33d9e3744902, replyNumber=0, likeNumber=81, createdTime=2022-10-01, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33d9e3744902, moduleTitle=胃蛋白酶原（PG）临床应用大全！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=33d9e3744902)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945249, encodeId=5dc319452499d, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, objectTitle=Cancer：HIV-1蛋白酶抑制剂奈非那韦联合标准放化疗治疗局部晚期宫颈癌的效果, objectType=article, longId=293023, objectId=5fe32930236d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5fe32930236d, replyNumber=0, likeNumber=68, createdTime=2022-12-07, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5fe32930236d, moduleTitle=Cancer：HIV-1蛋白酶抑制剂奈非那韦联合标准放化疗治疗局部晚期宫颈癌的效果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5fe32930236d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945244, encodeId=2fbf194524468, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, objectTitle=Arthritis Rheumatol：尿基质金属蛋白酶7与狼疮性肾炎发病的关系, objectType=article, longId=217610, objectId=3cc421e61061, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cc421e61061, replyNumber=0, likeNumber=91, createdTime=2022-05-23, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cc421e61061, moduleTitle=Arthritis Rheumatol：尿基质金属蛋白酶7与狼疮性肾炎发病的关系, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3cc421e61061)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945251, encodeId=dfcb1945251de, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, objectTitle=Front Immunol：类风湿性关节炎滑液中基质金属蛋白酶-9/明胶酶B的研究, objectType=article, longId=293640, objectId=9b32293640a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b32293640a7, replyNumber=0, likeNumber=81, createdTime=2022-08-15, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b32293640a7, moduleTitle=Front Immunol：类风湿性关节炎滑液中基质金属蛋白酶-9/明胶酶B的研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9b32293640a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945253, encodeId=14ee1945253bc, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, objectTitle=JEADV：分泌型白细胞蛋白酶抑制剂调节银屑病中神经反射介导的皮肤屏障功能, objectType=article, longId=301121, objectId=51443011213c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51443011213c, replyNumber=0, likeNumber=87, createdTime=2022-11-25, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51443011213c, moduleTitle=JEADV：分泌型白细胞蛋白酶抑制剂调节银屑病中神经反射介导的皮肤屏障功能, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=51443011213c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945246, encodeId=b7b5194524663, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, objectTitle=Eur Respir J：基质金属蛋白酶7可作为IPF患者的血液生物标志物, objectType=article, longId=218116, objectId=cba0218116db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cba0218116db, replyNumber=0, likeNumber=86, createdTime=2022-09-10, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cba0218116db, moduleTitle=Eur Respir J：基质金属蛋白酶7可作为IPF患者的血液生物标志物, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=cba0218116db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945241, encodeId=7589194524154, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, objectTitle=Cell：广谱抗癌疗法或将诞生，中性粒细胞的这种蛋白酶能够杀死各种癌细胞，且不伤害正常细胞, objectType=article, longId=211471, objectId=6d322114e1a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d322114e1a2, replyNumber=0, likeNumber=0, createdTime=2022-04-09, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d322114e1a2, moduleTitle=Cell：广谱抗癌疗法或将诞生，中性粒细胞的这种蛋白酶能够杀死各种癌细胞，且不伤害正常细胞, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6d322114e1a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945248, encodeId=cca719452483d, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, objectTitle=2021年11月19日简报：国内31省市累计接种新冠疫苗超24.02亿剂次；国内小分子3CL蛋白酶抑制剂SIM0417也将进入临床试验阶段, objectType=article, longId=220611, objectId=faab2206117b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=faab2206117b, replyNumber=0, likeNumber=80, createdTime=2022-03-17, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=faab2206117b, moduleTitle=2021年11月19日简报：国内31省市累计接种新冠疫苗超24.02亿剂次；国内小分子3CL蛋白酶抑制剂SIM0417也将进入临床试验阶段, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=faab2206117b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945242, encodeId=d102194524291, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, objectTitle=JGH：血清蛋白酶3抗中性粒细胞胞浆抗体（PR3-ANCA）对儿童溃疡性结肠炎具有良好的诊断价值, objectType=article, longId=212714, objectId=642a212e14ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=642a212e14ff, replyNumber=0, likeNumber=70, createdTime=2021-08-08, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=642a212e14ff, moduleTitle=JGH：血清蛋白酶3抗中性粒细胞胞浆抗体（PR3-ANCA）对儿童溃疡性结肠炎具有良好的诊断价值, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=642a212e14ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945247, encodeId=9f42194524e21, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, objectTitle=Front Immunol：蛋白酶体抑制剂硼替佐米治疗重症系统性红斑狼疮疗效和安全性的临床经验, objectType=article, longId=219213, objectId=3deb219213a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3deb219213a1, replyNumber=0, likeNumber=79, createdTime=2022-01-26, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3deb219213a1, moduleTitle=Front Immunol：蛋白酶体抑制剂硼替佐米治疗重症系统性红斑狼疮疗效和安全性的临床经验, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3deb219213a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945243, encodeId=199619452436d, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, objectTitle=Journal of stroke-脑中风取栓后,行纤维蛋白酶辅助治疗, 安全性和有效性如何？, objectType=article, longId=215216, objectId=53a22152169b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53a22152169b, replyNumber=0, likeNumber=74, createdTime=2022-02-23, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53a22152169b, moduleTitle=Journal of stroke-脑中风取栓后,行纤维蛋白酶辅助治疗, 安全性和有效性如何？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=53a22152169b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945240, encodeId=6158194524095, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, objectTitle=Cancer：HIV-1蛋白酶抑制剂奈非那韦联合标准放化疗治疗局部晚期宫颈癌的效果, objectType=article, longId=210992, objectId=3d082109924e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d082109924e, replyNumber=0, likeNumber=0, createdTime=2022-04-06, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d082109924e, moduleTitle=Cancer：HIV-1蛋白酶抑制剂奈非那韦联合标准放化疗治疗局部晚期宫颈癌的效果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3d082109924e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945238, encodeId=e2e01945238bb, content=<a href='/topic/show?id=249488e60fe' target=_blank style='color:#2F92EE;'>#蛋白酶#</a>, objectTitle=日本厚生劳动省（MHLW）批准α-1蛋白酶抑制剂Lynspad治疗α-1抗胰蛋白酶缺乏症, objectType=article, longId=206186, objectId=022b2061861a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=022b2061861a, replyNumber=0, likeNumber=101, createdTime=2021-11-14, rootId=0, userName=canlab, userId=512d422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=022b2061861a, moduleTitle=日本厚生劳动省（MHLW）批准α-1蛋白酶抑制剂Lynspad治疗α-1抗胰蛋白酶缺乏症, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=022b2061861a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

蛋白酶

2020-05-29

canlab (审核中...)

前往app查看评论内容

#蛋白酶#

《新英格兰医学杂志》发表Fazirsiran治疗α-1抗胰蛋白酶缺乏症患者的二期研究结果

2023-05-31

canlab (审核中...)

前往app查看评论内容

#蛋白酶#

众生药业抗新型冠状病毒3CL蛋白酶抑制剂一类创新药物RAY1216片获准IND

2023-01-07

canlab (审核中...)

前往app查看评论内容

#蛋白酶#

胃蛋白酶原（PG）临床应用大全！

2022-10-13

canlab (审核中...)

前往app查看评论内容

#蛋白酶#

欧洲药理学杂志：组织蛋白酶 S 抑制剂 ASP1617 作为系统性红斑狼疮治疗的潜在益处

2022-07-19

canlab (审核中...)

前往app查看评论内容

#蛋白酶#

J Am Acad Dermatol ：组织蛋白酶S抑制剂对中、重度银屑病患者疗效和安全性的研究

2022-07-29

canlab (审核中...)

前往app查看评论内容

#蛋白酶#

NEJM：Fazirsiran 治疗α1-抗胰蛋白酶缺乏症相关的肝病

2022-09-16

canlab (审核中...)

前往app查看评论内容

#蛋白酶#

A&R：PSMD12 的单倍体不足导致蛋白酶体功能障碍和亚临床自身炎症

2022-11-05

canlab (审核中...)

前往app查看评论内容

#蛋白酶#

胃蛋白酶原（PG）临床应用大全！

2022-10-01

canlab (审核中...)

前往app查看评论内容

#蛋白酶#

Cancer：HIV-1蛋白酶抑制剂奈非那韦联合标准放化疗治疗局部晚期宫颈癌的效果

2022-12-07

canlab (审核中...)

前往app查看评论内容

#蛋白酶#

Arthritis Rheumatol：尿基质金属蛋白酶7与狼疮性肾炎发病的关系

2022-05-23

canlab (审核中...)

前往app查看评论内容

#蛋白酶#

Front Immunol：类风湿性关节炎滑液中基质金属蛋白酶-9/明胶酶B的研究

2022-08-15

canlab (审核中...)

前往app查看评论内容

#蛋白酶#

JEADV：分泌型白细胞蛋白酶抑制剂调节银屑病中神经反射介导的皮肤屏障功能

2022-11-25

canlab (审核中...)

前往app查看评论内容

#蛋白酶#

Eur Respir J：基质金属蛋白酶7可作为IPF患者的血液生物标志物

2022-09-10

canlab (审核中...)

前往app查看评论内容

#蛋白酶#

Cell：广谱抗癌疗法或将诞生，中性粒细胞的这种蛋白酶能够杀死各种癌细胞，且不伤害正常细胞

2022-04-09

canlab (审核中...)

前往app查看评论内容

#蛋白酶#

2021年11月19日简报：国内31省市累计接种新冠疫苗超24.02亿剂次；国内小分子3CL蛋白酶抑制剂SIM0417也将进入临床试验阶段

2022-03-17

canlab (审核中...)

前往app查看评论内容

#蛋白酶#

JGH：血清蛋白酶3抗中性粒细胞胞浆抗体（PR3-ANCA）对儿童溃疡性结肠炎具有良好的诊断价值

2021-08-08

canlab (审核中...)

前往app查看评论内容

#蛋白酶#

Front Immunol：蛋白酶体抑制剂硼替佐米治疗重症系统性红斑狼疮疗效和安全性的临床经验

2022-01-26

canlab (审核中...)

前往app查看评论内容

#蛋白酶#

Journal of stroke-脑中风取栓后,行纤维蛋白酶辅助治疗, 安全性和有效性如何？

2022-02-23

canlab (审核中...)

前往app查看评论内容

#蛋白酶#

Cancer：HIV-1蛋白酶抑制剂奈非那韦联合标准放化疗治疗局部晚期宫颈癌的效果

2022-04-06

canlab (审核中...)

前往app查看评论内容

#蛋白酶#

日本厚生劳动省（MHLW）批准α-1蛋白酶抑制剂Lynspad治疗α-1抗胰蛋白酶缺乏症

2021-11-14

科室
- - 订阅+
  - 更多科室
工具
服务